Doses of vitamin C may reduce the duration and severity of cold symptoms, particularly in people who are vitamin C deficient. The effectiveness of vitamin C therapy on colds seems to be related to the person's dietary vitamin C intake and their general health and lifestyle. In addition, however, other researchers have found that vitamin C is associated with improved lung function and overall respiratory health.
| VITAMIN C DOSES FOR COMMON ILLNESSES | |
| Illness | Dose per 24 hours |
| Asthma | 5–20 grams (g); 4–8 doses per 24 hours |
| Hay fever | 5–20 grams (g); 4–8 doses per 24 hours |
| Common cold | 30–60 g; 6–10 doses per 24 hours |
| Influenza | 100–150 g; 8–15 doses per 24 hours |
| Viral pneumonia | 50–200+; 12–18 doses per 24 hours |
Some studies have indicated that vitamin C may prevent heart disease by lowering total blood cholesterol and LDL cholesterol and raising HDL, or good cholesterol, levels. The antioxidant properties of vitamin C have also been associated with protection of the arterial lining in patients with coronary artery disease. A study published in 2002 reported that the protective effects of vitamin C on the lining of the arteries reduces the risk of heart disease in patients who have received heart transplants.
On the other hand, the results of a recent study conducted at the University of Southern California and released in early 2000 have cast doubt on the heart protective benefits of vitamin C. The study found that daily doses of 500 mg of vitamin C resulted in a thickening of the arteries in study subjects at a rate 2.5 times faster than normal. Thicker arterial walls can cause narrow blood vessels and actually increase the risk for heart disease. Study researchers have postulated that the collagen-producing effects of vitamin C could be the cause behind the arterial thickening. Further studies will be needed to determine the actual risks and benefits of vitamin C in relation to heart disease and to establish what a beneficial dosage might be, if one exists. For the time being, it is wise for most individuals, particularly those with a history of heart disease, to avoid megadoses over 200 mg because of the risk of arterial thickening.
A 1999 study found that daily doses of 500 mg of vitamin C reduced blood pressure in a group of 39 hypertensive individuals. Scientists have hypothesized that vitamin C may improve high blood pressure by aiding the function of nitric oxide, a gas produced by the body that allows blood vessels to dilate and facilitates blood flow. Again, recent findings that vitamin C may promote arterial wall thickening seem to contradict these findings, and further long-term studies are needed to assess the full benefits and risks of vitamin C in relation to blood pressure control.
Researchers disagree on the therapeutic use of vitamin C in cancer treatment. On one hand, studies have shown that tumors and cancer cells absorb vitamin C at a faster rate than normal cells because they have lost the ability to transport the vitamin. In addition, radiation and chemotherapy work in part by stimulating oxidation and the growth of free radicals in order to stop cancer cell growth. Because vitamin C is an antioxidant, which absorbs free radicals and counteracts the oxidation process, some scientists believe it could be counterproductive to cancer treatments. The exact impact vitamin C has on patients undergoing chemotherapy and other cancer treatments is not fully understood, and for this reason many scientists believe that vitamin C should be avoided by patients undergoing cancer treatment.
On the other side of the debate are researchers who believe that high doses of vitamin C can protect normal cells and inhibit the growth of cancerous ones. In labbased, in vitro studies, cancer cells were killed and/or stopped growing when large doses of vitamin C were administered. Researchers postulate that unlike normal healthy cells, which will take what they need of a vitamin and then discard the rest, cancer cells continue to absorb antioxidant vitamins at excessive rates until the cell structure is effected, the cell is killed, or cell growth simply stops. However, it is important to note that there have been no in vivo controlled clinical studies to prove this theory.
Based on the currently available controlled clinical data, cancer patients should avoid taking vitamin C supplementation beyond their recommended daily allowance.
|
|
Author Info: Paula Ford-Martin, Rebecca J. Frey PhD, The Gale Group Inc., Gale, Detroit, Gale Encyclopedia of Alternative Medicine, 2005 |